Tephrosia purpurea (Linn.)Pers.- A Comprehensive Review
Devprakash1,3*, Sumalatha B.V.1, K.K. Srinivasan2, Savitha1
1Dept. of Pharmaceutical Chemistry, Bharathi College of Pharmacy, Bharathinagara,
K.M. Doddi Karnataka-571422.
2Dept of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal, Udupi, Karnataka-571419.
3Faculty of Pharmacy, Karpagam
University, Coimbatore-612001
ABSTRACT:
Tephrosia purpurea
(Linn.) Pers., a popular Indian medicinal plant, has long been used
commonly in Ayurvedic and unani
system of medicine. In the present review, an attempt has been made to explore
a literature survey on its traditional uses, established phytochemical studies
and pharmacological properties. The whole plant as well as specific parts such
as roots, leaves, seeds and bark have been widely used and shows the different
pharmacological activities such as antimicrobial, anti-inflammatory,
hepatoprotective,anti-ulcer,anti-epileptic,antibiotic,anticarcinogenic, antilipid peroxidative, wound
healing, antidiabetic, antioxidant etc.
KEYWORDS: Tephrosia purpurea , Traditional
uses, Phytoconstituents, Pharmacological activities.
INTRODUCTION:
Medicinal plants have been a major source of therapeutic agents
since ancient times to cure human disease. India is considered as “Botanical
Garden of the world” and more than 2200 species of medicinal and aromatic
plants have been identified after studies. The revival of interest in natural
drugs started in last decade mainly because of the wide spread belief that
green medicine is healthier than synthetic products. Now-a-days, there is
manifold increase in medicinal plant based industries due to the increase in
the interest of use of medicinal plants throughout the world which are growing
at a rate of 7-15% annually. Despite the major advances in the modern medicine,
the development of new drugs from natural products is still considered
important. This seems to be even more relevant for the developing countries,
where the cost to develop a drug is prohibitive. Since 1980, the World Health
Organization has been encouraging countries to identify and exploit traditional
medicine and phytotherapy. The Indian Traditional
systems of medicine namely Ayurveda and Siddha are primarily plant based system. The evaluation of
new drugs especially phytochemically obtained
materials has again opened a vast area for research and development. As per WHO, about 80% of the population in the world relay on the
traditional medicine for the treatment of various diseases. Therefore,
the evaluation of rich heritage of traditional medicine is essential1.
In this
regard, one of the such plant is Tephrosia purpurea (Linn.) pers, (fig:4)belongs to
family Fabaceae, and it is a highly branched suberectherbaceous perennial, upto60 m in height with
spreading branches; the leaves are imparipinnate,
with narrow, oblanceolate leaflets; the flowers are
red or purple in extra-axillary racemes, the pods are
slightly curved, 3-4.5 cm long, grey, smooth and containing 5-10 seeds per pod.
The plant grows abundantly in the upper Gangeticplains,
and western Himalayas. The herb is commonly grown as a green manure in paddy
fields in India and in tobacco and rubber plantation in other countries.
It grows uniquitouslyin all soils,
sandy, rocky, and loamy. In India and South Africa, it is used as a fodder
before flowering, but in Australia it is reported to cause livestock poisoning2.
Tephrosia purpurea Linn. is commonly known as wild indigoin
English, Kolanjiin Tamil, sharapunkhain
Sanskrit, Sarponkhain Hindi, Thilain
Gujarati, Vempaliin Telugu3-4-5 . According
to Ayverveda literature this plant has also given the
name of wranvishapakawhich
means that it has the property of healing all types of wounds6.It
has been used in Ayurvedic system, Siddha, unani system of medicine for the treatment of various diseases.
Experimental studies suggest that Tephrosia purpurea Linn exerts anti-ulcer, anti-oxidant, hepatoproductive and hypoglycaemic
activities. It has been reported to possess hepatoprotective
and mast cell stabilising effect in various
experimental models7.
Species
of Tephrosia
The genus Tephrosia
is a Pantropical taxa with about
400 species distributed chiefly in Asia, Africa, Australia.
Tephrosia belongs
to the family Fabaceae (Leguminosae)
and has earlier been classified by many taxonomists either into sections of subgenera, based mainly on the morphological traits classified
Tephrosia into
four sections namely Mundulea, Brissonia, Croccoides and Reineria. Of these only mundulea and Reineria, which
includes rest of species of Tephrosia. Wood categorized the new world species of Tephrosiainto groups,
one with a glasrous style and the other with a pubescent
style. Gillett adopted this classification in African species of Tephrosia. Subseguently Brurnmitt divided Tephrosiainto subgenera,
subg. Tephrosia with a glabrous style (according to which T. hamiltonii, T. Pumila,
T. purpurea, T. spinosa, T.
Strigosa, T.villosa etc.
Were included) and subg. Barbisyla with a trichiferous style (which includes
T. candida, T. maxima,
T. pulcherima, T. tinctoriaetc). The above classification
was criticized since same of the taxa (T. pumila T. maxima etc.) showed bothglabrous
and trichiferous styles8.
Other species of Tephrosia
Tephrosia vogelii
1. Tephrosia kerrii
2.
Tephrosia vestita
3.
Tephrosia noctiflora
4.
Tephrosia ionophlebia
5.
Tephrosia coccinea
6.
Tephrosia luzonensis
7.
Tephrosia obovata.
Tephrosia kerrii
Herbs, perennial, to 3 m tall, densely yellow spreading villous. Stems erect, sturdy, ridged, apically branched. Leaves 11–17-foliolate; rachis 9–15 cm, including petiole ca. 5 mm;
leaflet blades oblong-lanceolate, 5–8 × 1.5–2 cm, abaxially densely silverysericeous,
adaxially olive-green and glabrous, secondary veins 20
on each side of midvein and conspicuous, base obtuse
to cuneate, apex acute and cuspidate. Pseudoracemes terminal,
when immature cone-shaped and covered by bracts, elongated to ca. 10 cm at anthesis. Pedice ca. 5 mm,
densely white sericeous. Flowers ca.2.2
cm. Calyx ca. 8 × 6 mm; teeth narrowly triangular, most abaxial
one longest and ca. 5 mm apex acute. Corolla red; standard
obovate, yellow sericeous.
Ovary sericeous, with numerous ovules.
Legume linear, 8–10 cm × 6–8 mm, straight, spreading and slightly nodding, yellow
sericeous, apex with a ca. 1 cm slightly ascending beak.
Seeds 10–12 per legume but characters unknown.
Tephrosia vestita
Herbs, perennial, suffrutescent,
1–2 m tall, many branched, yellowish white velutinous. Stems zigzag ascending, ridged. Leaves
7–11 (or 13)-foliolate; rachis ca. 10 cm, including petiole1–1.5
cm; leaflet blades obovate-elliptic to narrowly elliptic,
2–4 × 1–1.8 cm, abaxially velutinous,
adaxially rough and glabrous, secondary veins 15–20 on
each side of midvein, base cuneate,
apex rounded to retuse. Pseudoracemes terminal or opposite leaf
near apex of branchlets, 3–7 cm, with congested flowers.
Pedicel ca. 2 mm. Flowers ca. 1.7 cm, fragrant. Calyx ca. 3× 4 mm. Corolla white; standard suborbicular,
yellow velutinous. Ovary sericeous, with numerous ovules. Legume linear, 5.5–6
cm × ca. 5 mm, straight, flat, densely yellow velutinous,
apex abruptly pointed and with a ca. 1 cm beak. Seeds 10–12per
legume, black, reniform, ca. 3 × 2.5 mm.
Tephrosia coccinea
Herbs, perennial, suffrutescent, 40–50 cm
tall, many branched. Stems woody, terete;
young branchlets 4-sided, silveryor
white appressedsericeous. Leaves subsessile, 5- or 7(or9)-foliolate;
rachis 6–10 cm; leaflet blades linear-oblanceolateto oblong-oblanceolate, 4–6 × ca. 1 cm with basal pair smallest and terminal
one longest, abaxially silvery sericeous,
secondary veins 9 or 10 on each side of midvein. Pseudoracemes terminal
or opposite a leaf, ca. 25 cm, with scattered flowers. Pedicel 3–6 mm. Flowers ca. 1 cm. Calyx ca. 5 mm. Corolla red; standard
orbicular, outside sericeous, inside glabrous.
Ovary stipitate, sericeous, with 10–12 ovules. Legume
linear, ca. 6 cm × 7–8 mm, flat, tomentose. Seeds 8–12 per legume, black, reniform, ca.
8 × 5 mm.
Tephrosia pumila
Herbs, annual or perennial, procumbent or straggling,
20–30 cm tall. Stems thin
and hard, ridged, densely spreading strigose. Stipules 3–4 mm. Leaves 7(–13)-foliolate; rachis 2–4 cm, including petiole 3–10 mm; leaflet
blades narrowly obovatetooblanceolate, 1.2–2 ×
0.4–0.8 cm, abaxiallystrigose, adaxially
appressed pubescent, secondary veins 6 or 7 on each side
of midvein and obscure, base cuneate,
apex truncate to obtuse and cuspidate. Pseudoracemes terminal or opposite a leaf, ca. 2 cm, strigose,
with 1–3 flowers. Pedicel 2.5–4 mm. Flowers ca. 6mm. Calyx ca. 3 × 2 mm.
Corolla white, yellow, or rarely palepink; standard orbicular,
pilose. Ovary withtrichomes,
with numerous ovules. Legume linear, 3.5–4 cm × ca. 4 mm, shortly strigose, apex slightly ascending curved and
with a beak; styleremnant sharply reflexed. Seeds 8–14 per legume, brown, oblong-rhomboid, ca.
4 × 3 mm, mottled.
Tephrosia noctiflora
Herbs, perennial, suffrutescent,
0.5–1.5 m tall. Stems terete, with dense spreading trichomes. Stipules narrowly triangular, 6–11 mm, persistent,
apex acuminate. Leaves 15–25-foliolate; rachis 7–11 cm,
including petiole 0.7–1.3 cm; leaf letblades oblong-oblanceolate, 2.2–3.2 × 0.5–0.8 cm with terminalone
slightly larger than others, abaxially densely appressedsericeous, adaxiallyglabrous,
secondary veins 9–11 on each side of midvein, base cuneate, apex rounded to retuse and
cuspidate. Pseudoracemes terminal, 15–25 cm, rigid and straight, with scattered flowers.
Pedicel 2–4 mm. Flowers ca. 1 cm. Calyx ca. 5 ×5 mm, densely brown pubescent; teeth
unequal, most abaxialone 4–6 mm and narrow, other ones
short and broad. Corolla yellow, violet, or white; standard orbicular,
brown sericeous. Ovary sericeous, with numerous ovules. Legume
linear, 4.5–5 cm × ca. 5 mm, straight, densely brown pubescent, apex ascending curved.
Seeds 7–9 per legume, black, reniform,
ca. 4× 2.5 mm, usually transversely rugose.
Tephrosia pumila
Herbs, annual or perennial, procumbent or straggling,
20–30 cm tall. Stems thin
and hard, ridged, densely spreading strigose. Stipules 3–4 mm. Leaves 7(–13)-foliolate; rachis 2–4 cm, including petiole 3–10 mm; leaflet
blades narrowly obovate to oblanceolate,
1.2–2 × 0.4–0.8 cm, abaxiallystrigose, adaxially appressed pubescent, secondary
veins 6 or 7 on each side of midvein and obscure, base
cuneate, apex truncate to obtuse and cuspidate. Pseudoracemes terminal
or opposite a leaf, ca. 2 cm, strigose, with 1–3 flowers.
Pedicel 2.5–4 mm. Flowers ca. 6 mm. Calyx ca. 3 × 2 mm. Corolla white, yellow, or
rarely pale pink; standard orbicular, pilose. Ovary with trichomes, with numerous ovules.
Legume linear, 3.5–4 cm × ca. 4 mm, shortly strigose,
apex slightly ascending curved and with a beak; styleremnant
sharply reflexed. Seeds 8–14 per legume, brown, oblong-rhomboid,
ca. 4 × 3 mm, mottled.
Tephrosiao bovata
Herbs, perennial, small. Stems straggling, appressed pubescent, base woody. Stipules subulate, 2–4 mm. Leaves (9or) 11- or 13-foliolate; rachis ca.
5 cm, including petiole ca. 1.5 cm; leaflet blades obovate,
ca. 1.4 × 0.6 cm, both surfaces appressedsericeous but
abaxially especially dense,
secondary veins 5–8 on each side of midvein and obscure,
base roundedcuneate, apex emarginate and cuspidate. Pseudoracemesterminalor axillary, short. Flowers ca. 1 cm.
Calyx campanulate, ca.3 mm. Corolla red; standard orbicular,
outside pubescent. Ovary withtrichomes.
Legume linear, 2–2.5 cm × ca. 4 mm, straight, densely velutinous. Seeds 6 or 7 per legume,
pale brown, ellipsoid, ca. 2.5 × 2.2 mm.
Tephrosia purpurea
Plants ± pubescent. Stipules ca. 4 mm. Leaflet
blades oblong-elliptic to oblanceolate-elliptic, 1.5–3.5
× 0.4–1.4 cm, abaxially appressed
pubescent, adaxiallyglabrous. Racemes ca.10 cm, slender. Legume 4–5 cm ×
4(–6) mm, with trichomes. Seeds grayish brown,
spotted, smooth9.
Taxonomy, Morphological and Microscopic characteristics
of Tephrrosia purpurea
Taxonomy
Tephrosia purpurea(Linn.) Pers. belongs to the family Fabaceae, occurs throughoutthe
Indian subcontinent, thrives well in sandy or loamysoils and also in rocky areas. Tephrosia purpurea (Linn.) Pers.is
a copiously branched herbaceous perennial, 30-60cm high, branches spreading, glabrousor sparsely pilose. Leaves 5-10 cm long, petioles 6-12 mm long, stipules linear-subulate, nerved, erect or sometimes reflexed.
Leaflets11-21, oblanceolate, obtuse or retuse, mucronate, size ofleaflets varies from 2-2.8 by 0.8-1.2 cm, glabrousabove, clothed with fine appressed
silky hair beneath, base cuneate; nerves close,
ascending, slender, conspicuous on bothsurfaces; petiolulesof lateral leaflets 1.5-2.5 mm long.
Tephrosiapur purea roots were 8 to 25 cm long, cylindrical, tortuous,
tapering and branched with lateral roots;bitter in
taste, 0.4 to 4 cm in diameter, surface rough, longitudinally wrinkled and
cracked, at places transversely cracked exposing the inner light solid wood.
Scars left by the removal of the lateral roots are so prominent, externally brownish
yellow, internally pale yellow. Smooth transversely cut surface of the root is
circular with thin cork and narrow cortex. Many lateral roots with 2 to 6 cm
long, fibrous, externally and internally brownish and pale brown in color respectively.
Morphological and Microscopic
characteristics of Tephrosiapurpurea root
Macroscopic
characters
Microscopic
characteristics
Transverse section of Tephrosia
purpurea root
Transverse section
of mature root
showed a well developed periderm consisting
of 6 to
10 layers of
cork cells,2 to 4 layers
of phelloderm and
several layers of
cortex. Cork
cells are tangentially
elongated and suberised. Phelloderm is composed
of thin-walled parenchymatous cells
filled with starch
grains and prisms
of calcium oxalate crystals.
Cortex has parenchymatous cells
containing prisms of
calcium oxalate crystals
and starch grains. Groups of thick walled pericyclic fibres are present at
the lower end of cortex. Thick walled fibres, solitaryor in groups of two ormore
were present in phloem.
Photoplate
shows various layers in roots 10x (figure2a) and xylem and medullary
rays in roots 40x (figure 2b)Many cells containing
prisms of calcium oxalate crystals are associated with each group of fibres; starch grains are present in phloem parenchyma.
Xylem vessel elements distributed singly or in groups of 2 to 4. Starch grains
and prisms of calcium oxalate crystals are present in the medullary
ray cells. The microscopic characters of roots can serve as diagnostic
character and helpful in differentiation of species as well as identification
of particular herb. We observed some morphological characters like number of
leaflet is varied from one region to another region. Most of the microscopical characters of Tephrosiapurpurea
roots are almost similar except we found the reticulate xylem vessel in our
study. (Figure 2)
Powder characteristic of Tephrosia purpurea root
Powder was light
brown in colour and odor was not characteristic. It
was slightly bitter in taste. Microscopic study of powder showed various
characters such as phloem fibres, concentric starch
grains, pitted and border pitted xylem vessels, reticulate xylem vessels,
crystal fibres and groups of cork cells shown in
Figure 3.
Formulations ofTephrosia purpurea
1.
Routack
Routack is one such polyherbal
formulation containing the whole dried plant of Tephrosiapurpurea. These ingredients have specific
properties thatmay be useful in ameliorating the pathophysiology
of anaphylaxis. The protective effect of
this formulation in two different rodent models of anaphylaxis. The models
represented the condition developed during an anaphylactic attack. In both these studies, the
results suggested that routack offered
significant protective effect against anaphylaxis, albeit at higher doses. The polyherbal formulation exhibited substantial protective
effect against triple antigen induced anaphylaxis in rats. Routack was uncovered of its activity against systemic anaphylaxis
induced by mast cell secretagogue, compound 48/80.
This effect can be translated to the clinical side if the formulation can be
incorporated as a dietary supplement in patients who are at risk of developing anaphylaxis.
The 200
mg/kg and 400
mg/kg of routack was
showed significant protective
effect11.
2. Livergen
Polyherbal formulations
available with a wide range
of indications like
protective to liver, appetite and
growth promoters, gastrointestinal and
hepatic regulator, as
treatment for hepatic dysfunction, for
hepatic regeneration as
well as liver
stimulant and tonic.
Despite the widespread
use, there is
a lack of scientific evidence
on their efficacy
and safety. A polyherbal
hepatoprotective formulation, namely Livergen was selected from Tephrosia purpurea. The criteria for selection was based on (i) claimed as Ayurvedic medicine, (ii)commercially
available, (iii) liquid formulations for easy administration, (iv) with
known hepatoprotective and (v) sufficient
shelf life. This herbal drug have been traditionally used for liver diseases
and the polyherbal formulations, claimed to be
Ayurvedic medicines are being sold as liver tonics. The polyherbal hepatoprotective
formulation Livergen was effective
as hepatoprotective agent
in normal dose (2.60 ml/kg bw,
orally). The Polyherbal
formulation Livergen had shown significant hepatoprptective activity
by decreasing the enzyme
level of SGOT,
SGPT, ALP, Cholesterol,
Bilirubin
and significant increase
in enzyme level
of Total protein (P< 0.01)12.
3. Hepjaun (HA-I)
HA-I is one of
the well known
proprietary polyherbal formulation,
containing aqueous extracts
of Tephrosia purpurea crude
drugs. The Hepatoprotective activity
of Hepjaun syrup (HA-I) and
Modified Formulations (HA-II
and HA-III) were
evaluated and compared
statistically after inducing
hepatotoxicity
in rats by subcutaneous administration of
carbon tetra chloride (CCL4) with
olive oil as a
diluent in 1:1
%v/v on 2nd
and 3rd day.
The liver damage
was confirmed by
estimation of elevated
levels of Serum
Glutamate Oxaloacetate Transaminase (SGOT),
Serum Glutamate Pyruvate Transaminase (SGPT),
Alkaline Phosphatase (ALP),
serum bilirubin and
liver weights. HA-I, HA-II, HA-III
pretreatment (500mg/kg) significantly
reduces the CCl4
induced elevated serum levels
of SGOT, SGPT,
SALP and Serum
Bilirubin13.
Traditional uses
In the Ayurvedic system of medicine,
various parts of this plant are used as remedies for impotence, asthma, diarrhoea, gonorrhoea, rheumatism, ulcers and urinary
disorders. The plant has been claimed to cure diseases of kidney, liver, spleen,
heart, and blood. The dried herb is effective as a tonic laxative, diuretic,
and deobstruent. It is also used in the treatment of
bronchitis, bilious febrile attacks, boils, pimples and bleeding piles. The
roots and seeds reported to have insecticidal and piscicidal
properties and they are also used as a vermifuge. In
addition, the roots are reported to be effective in the treatment of leprous
lesions while their juice is used to treat skin eruptions. An extract of the
pods is effective for the treatment of pain, inflammation and their decoction
is used to combat vomiting14.
The roots are
useful in inflammation,
skin diseases, scrofula,
elephantiasiasis, dyspepsia,
stomachalgia,
flatulence, haemorrhoids, asthma,
bronchitis, ananemia, hepatosplenomegaly, verminosis, strangury, dysmenorrhoea, chronic
fever, boils, pimples,
odontalgia
and gingivitis. In
traditional Indian medicine,
Tephrosiapurpurea is
a common ingredient
of formulations for
liver ailments and
used for different
remedies such as
bilious febrile attacks,
liver and splenic affections,
cirrhosis, hepatitis, piles,
syphills
and gonorrhoea. It is
considered beneficial for
liver, kidney, and
spleen disorders15.
Phytochemical studies
The preliminary phytochemical study investigation of all the
extract shows the presence of Anthraquinone. Pet ether and ethanol extract
shows presence of alkaloids, steroids and sterols, triterpenoids
and fixed oil. Ethanol and aqueous extracts shows the presence of flavonoids, while as aqueous extract shows presence of
carbohydrate, Protein, Amino acid, tannins and phenolic
compounds and saponins16.The plant of Tephrosia purpurea Linn also shows the presence of
glycosides, rotenoids, isoflavones,
flavanones, chalcones, flavanols, flavones and sterols17,coumarins,
quercetins18.
Flavonoids like tephrosin, pongaglabol
and semiglabrin have been isolated from aerial parts
of the plant19. Recently invented constituents are as an isoflavone, 7,4-dihydroxy-3,5-dimethoxyisoflavone,
and a -tephropurpurin, lanceolatin B, maackiain, 9-methylene-dioxypterocarpan, medicarpin, rotenone, deguelins.
Three novel flavonoids, (+)-tephrosinsA,
and B and (+)-tephrosone, were also isolated from Tephrosia purpurea. The
leaves contain up to 2.5 rutin7,2%
glycoside osyritin, β-sitosteroland lupeoland
root contain isotephrosin20.
Rotenoides and flavonoides like
isolonchocarpin and lanceolatin
A, lanceolatinB21, Purpurenone, a new β-hydroxychalcone,
(+)-purpurin, a diasteroisoer
of (-)-purpurin, dehydroisodernicin,
and (-)-maackiain have been isolated from roots of Tephrosia purpurea22. A new flavone, psedosemiglabrinolhas
been isolated along with semiglabrino[23.Two new prenylated
flavonoids, purpuriteninand
purpureamethide, have been characterised
from the seeds of Tephrosia purpurea together
with the known compounds karanjin, kanjone and sitosterol24. Flavonolslike karanjonoland
dibenzoyl methanes like o-methylpongamolhave
been isolated from plant of Tephrosia purpurea25.
A new prenylated flavone,
named terpurin flavones has been isolated from the
stem of this plant26.A new flavanone purpurin has been
isolated from benzene extract27and pongamol
in its pure enol form has been isolated from the
petrol and benzene extracts of whole plant together with β-sitosterol, ursolic
acid and spinasterol by column chromatography28.
Pharmacological studies
Antibacterial activity
The
methanolic extract of
roots was evaluated
by Gupta at al29, for
its in vitro antimicrobial
properties by agar
disc diffusion method.
The crude methanolic extract
of Tephrosia purpurea at the
concentration ranging between
250 µg/ml and
1000 µ/ml inhibited
the growth of
both Gram positive
bacteria (Bacillus subtilis, Staphylococcus aureus pers. Micrococcus
luteus)
and Gram negative
bacteria (Escherichia coli, Pseudomsonas aeruginosa and
Salmonella typhimurium). The
Gram positive bacteria
tested appeared to
be more susceptible
to the extract
than the Gram
negative bacteria. The
extract also showed
significant antifungal activity
against Aspergillus niger and Candida
albicans.
In another study
by Abayasekara30, ethanolic
root extracts of Tephrosia purpurea were
found to be
active against
p. Aeruginosa, two
other pseudomonas strains
and two coliform strains.
Priliminary testing of
antimicrobial activity of T. Purpurea against 3
standard cultures (Staphylococcus aureus,
Pseudomonas aeruginosa, E.
Coli) and one clinical
isolate of Candida spp. Was performed
with water extracts
of leaves, pods
and roots using
the ‘disc diffusion
bioassay’. Subsequently, the
antimicrobial activity of
ethanolic root and leaf
extracts against the
above three standard
isolates and clinical
isolates of two
strains of Staphylococcus, two
strains of Pseudomonas and
nine coliforms were
tested using the
‘well method’. The
active extracts were
subjected to the
Minimum Inhibitory Concentration
agar dilution of
each extract. The
ethanolic extract of Tephrosia purpurea
(128 mg/dm3) showed
the significant antibiotic
activity against the
two strains of Staphylococcus, two
strains of pseudomonas
and nine coliforms.
Anti-inflammatory activity
The
ethanolic extract of
orally administered Tephrosia purpurea
was evaluated by Shenoy Smitha at al31, for
its anti-inflammatory activity
inacute
and sub acute inflammation.
Carrageenan
induced paw edema
and cotton pellet
granuloma
were the two
models for acute
and subacute inflammation.
The ethanolic extract
of orally administered
Tephrosia purpurea (100mg/kg)
significant anti-inflammatory effect
in sub acute inflammation
but not in
acute inflammation in
rats by comparing
with standard aspirin.
In
another study by
Gopalakrishna32,
ethanolic extracts of Tephrosia purpurea (250, 500mg/kg,
b.w)
roots and aerial
parts shows significant
in acute and
sub acute as well
as analgesic activity
by tail immersion
method. Furthermore, the
activities of the
plant extracts were
compared with the
standard indomethacin (20mg/kg,
ip).
Sree Rama Murthy at al33, studied
the hepatoprotective effect
of Tephrosia purpurea
in rats by inducing
hepatotoxicity
with D-galactosamine
HCl
(acute) and carbon
tetrachloride (chronic). Tephrosia purpurea
(aerial parts) powder
was administered orally
at a dose
of 500mg/kg. Serum
levels of transaminases (SGOT and
SGPT) and bilirubin were
used as the
biochemical markers of hepatotoxicity. Histopathological changes in
the liver were
also studied. The
results of the
study indicated that
the administration of tephrosia along with
the hepatotoxins offered
a protective action
in both acute
(D-galactosamine) and
chronic (CCl4) models.
In another study
by Jain34, ethanolic
extract of leaves
and flavonoid (isolated
from leaves extract)
from Tephrosia purpurea
were evaluated for hepatoprotective
activity in rats
by inducing hepatotoxicity with
carbon tetrachloride. These fractions were
administered orally at
a dose 100
mg/kg/day. Serum level
of transaminases, alkaline
phosphate, and total bilirubin were used
as biochemical markers
of the study
indicated that the hepatoprotective
changes in the
liver were also
studied. The results
of the study
indicated that the hepatoprotective
activity was more
in ethanolic extract
of leaves than
isolated flavonoid.
Antihyperglycimic andAntilipidperoxidative activity
Sethupathy
at al35, studied the antihyperglycemic
and antilipidperoxidative effects
of ethanolic seed
extract of Tephrosia purpurea (TpEt) in streptozocin induced
diabetic rats. Hyperglycemic
associated with an
altered hexokinase and
glucose 6 phosphatase activities,
elevated lipid per oxidative, disturbed
enzymatic and non-enzymatic
antioxidants status were
observed in streptozotocin induced
diabetic rats. Oral
administration of “TpEt” at
a dose 300mg/kg
bw
showed significant antihyperglycemic and antilipidperoxidative
effects as well as
increased the activities
of enzymatic antioxidants
and levels of
non enzymatic antioxidants.
The antihyperglycemic effect
of plant drug (TpEt) was comparable
to that of
the reference drug glibenclamide.
Antiepileptic activity
The
ethanolic extract of
the Tephrosia purpurea
was found to
be useful to
be useful to
control lithium-pilocarpine status epilepticus in
albino rats of wistar strain. Status epilepticus was induced
in male albino
rats of wistar strain
by administration of pilocarpine
(30mg/kg, i.p.) 24 after lithium chloride
(3mEq/kg, i.p). Different
doses of the
extract of Tephrosia purpurea
were administered orally
one hour before
the injection of pilocarpine.
The severity of
the status epilepticus was
reduced with the
administration of ethanolic
extract of Tephrosia purpurea (250, 500, and
1000mg/kg) orally36.
Anti-helicobacter
pyroli activity
The methanolic extract (50µg/ml or
25µl) showed promising
activity against clinical
isolates and standard
strains of Helicobacter pyroli, including
metronidazole-resistant strains.
Fractionation of the
extract revealed the
n-hexane and chloroform
fractions to possess
marked activity. The
extract and the
less polar fractions
remained functionally active
in acidic condition
similar to stomach
environment, exhibited consistent bacteriostatic activity
during repeated exposure,
and demonstrated synergism,
complete or partial,
even with antibiotic-resistant strains37.
Antihyperlipidemic activity
The ethanolic
extract of leaves
of Tephrosia purpurea
Linn. was
evaluated the lipid
lowering properties on
experimentally Dexamethasone
induced rats. The
lipid parameters studied
are Total cholesterol(TC), low
density lipoprotein cholesterol
(LDL-C), High density
lipoprotein cholesterol (HDL-C),
very low density
lipoprotein cholesterol (VLD-C),
Triglycerides and atherogenic index.
Extract was administered
orally for eight
days at a
dose of 600
and 1200mg/kg in Dexamethasone
induced rats. The level of TC,
LDL-C, VLDL-C, and
Triglycerides were reduced
significantly. (p<0.001) while
HDL-C level was
significantly increased when
compared to control
groups of rats.
In conclusion these
suggested that ethanolic
extract of leaves
of Tephrosia purpurea
Linn. can
reduce the lipid
levels significantly38.
Antiulcer activity
Theaqueous
extract (1 to
20 mg/kg) of
roots of Tephrosia purpurea
(AETP) showed significant
antiulcer activity in
rats in which
gastric ulcers were
induced by oral
administration of ethanol
or 0.6 M
HCL or indomethacin or by pyrolic
ligation and duodenal
ulcers were induced
by oral administration of cysteamine HCL.
AETP was administration in
the dose of
1 to 20
mg/kg orally 30
min prior to ulcer induction.
The antiulcer activity
was assessed by
determining and comparing
the ulcer index
in the drug
group with that
of the vehicle
control group. Gastric
total acid output
and pepsin activity
were estimated in the pylorus
ligated
rats. Omeprazole was
used as a
reference drug39.
Antioxidant activity
The
ethanolic extract of Tephrosia purpurea (100, 200,
and 400mg/kg) exhibits
antioxidant activity in vivo
and the ethyl
acetate soluble fraction
has improved antioxidant
potential than the
extract. The ethyl
acetate fraction of
the same extract
was studied for
free radial scavenging
and antilipidperoxidation activity.
The IC50 values
in both of
these in vivo assays were
found to be
significantly reduced for
ethyl acetate fraction
compared with the
ethanolic extract of
the plant. The
observation was further
supported by comparing
the in vivo antioxidant
activity for both
the ethanolic extract
and its ethyl
acetate fraction40.
Wound healing activity
The
plant Tephrosia purpurea
was found to
be effective in
healing external wounds.
Wound healing potential of
ethanolic extract of Tephrosia purpurea
(5% w/w) (aerial
part) in the
form of simple
ointment using three
types of wound
models in rats
as incision wound,
excite on wound and
space wound. The
results were comparable
to standard drug fluticasone
propionate ointment, in terms
of wound contraction,
tensile strength, hitopathological and
biochemical parameters such
as hydroxyproline content,
protein level, etc41.
Anti-allergic activity
The
ethanolic extract of
the aerial parts
of Tephrosia purpurea
administered orally at
a doses of
50,100 and 200
mg/kg, significantly reduced
an elevated WBC
count in response
to antigen challenge
in sensitized mice.
The extract also
significantly inhibited eosinophil infiltration
without any significant
change in the
mononuclear cell population.
The extract
failed to alter neutrophil
adhesion to nylon fibres.
However, it produced
a significant inhibitory
activity on enzyme
lipoxygenase
at concentrations of
100 and 200
µg/ml. The inhibitory
effect of ethanolic
extract of Tephrosia purpurea on late-phase
allergy could be
attributed to the
inhibition of leukotriene synthesis42.
Anticarcinogenic activity
The ethanolic
root extract of Tephrosia purpurea
(Linn.) Pers. (TpEt)showed the
chemo preventive potential on 7, 12-dimethylbenz(a)anthracene (DMBA)-
induced hamster buccal pouch carcinoma.
Oral administration of TpEt at a
dose of 300mg/kg,
b.w.,
to DMBA (on
alternate days for
14 weeks)- painted
animals significantly prevented
the incidence, volume
and burden of
the tumor43.
Anthelmintic activity
The Pet ether, Ethanol,
Aqueous extracts of
seeds of Tephrosia purpurea Linn.
exhibited anthelmintic activity
in dose-dependent manner
giving shortest time
of paralysis and
death with 100mg/ml
concentration for Pheretima posthuma. Pet ether
extract cause paralysis
of 27min and
earthworm remain alive
for 60 min.,
the aqueous extract
shows paralysis within
10.4 min and
time of death
46.2 min and
the ethanolic extract
of Tephrosia purpurea
Linn. cause paralysis
within 5.4 min
and time of
death 10.6 min.
Ethanolic extract (50,
100mg/ml) was found
to be most
potent among the
all extract44.
Anxiolytic activity
The hydroalcoholic extract
of Tephrosia purpurea
(L) Pers (HAETP)
was evaluated the anxiolytic
activity in mice
using the elevated
plus-maze (EPM), elevated
zero-maze(EZM), Y-maze and
hole-board models. Furthermore,
the anxiolytic effects
of HAETP were
compared to a
known active anxiolytic drug
diazepam. The extract,
administered orally, in
two different doses
of HAETP 200mg/kg
and 400 mg/kg,
was able to
increase the time
spent and the
number of arm
entries in the
open arms of
the elevated plus-maze
and elevated zero-maze,
as well as
decrease the visits
by mice in
the Y-maze, also
significantly increase nose
poking, line crossing
and rearing in
hole-board. This effect
was comparable to
that of the
diazepam (2.0mg/kg). These
results indicate that hydroalcoholic
extract Tephrosia purpurea
(L) Pers is
an effective anxiolytic agent45.
CONCLUSION:
In
recent years, ethnobotanical and
traditional uses of
natural compounds, especially
of plant origin
received much attention
as they are
well tested for
their efficacy and
generally believed to be
safe for human
use. They obviously
deserve scrutiny on
modern scientific lines
such as phytochemical
investigation, biological evaluation
on experimental animal
models, toxicity studies
and investigation of molecular
mechanism of actions
of isolated phytoconstituents. Tephrosia purpurea is reported
to possess antibacterial, anti-inflammatory, hepatoprotective, antihyperglycemic, antilipidperoxidative, antioxidative, antiallergic, anticarcinogenic, anti-helicobacter pyroli, antiulcer,
antihyperlipidemic, antiepileptic, wound
healing, anxiolytic and anthelmintic
activities but number
of other pharmacological activities
are yet to
be explored. The
review emphasis on the utility
of Tephrosia purpurea in Ayurvedic well
established now in
modern medicine system.
In future studies,
the isolated principles
from different parts
of the plant
needs to be
evaluated in scientific
manner using specific
experimental animal models
and clinical specific
experimental animal models
and clinical trials
are to be
bone to understand
the molecular mechanism
of action, in
search of lead
molecule from natural
resources.
REFERENCES
1.
Paarakh PM: Negellasativa Linn.-
A comprehensive review.
Ind J Nat prod Res 2010;1(4):409-429.
2.
Khalafalah AK, Yousef AH, Esmail AM, Abdelrazik MH,
Mohamed HH at al.,
studied the Chemical
constituents of Tephrosia purpurea, Pharmacognosy
Research 2010;2(2):1-3.
3.
Gopalakrishna S, Vadivel E, and
Dhanalaskshmi.Phytochemical andpharmacognostical studies
of TephrosiapurpureaLinn. aerialand root parts.
J Herbal MedToxicol
2009;3(2):73-78.
4.
Hegazy M-EF.Rare prenylated flavonoids from Tephrosia purpurea. Phytochemistry 2009;70:1474-1477.
5.
Patel A, Amit P and Patel
NM. Estimation of Flavonoid, Polyphenolic
Content and In-vitro
Antioxidant Capacity of
leaves of Tephrosia purpurea. IJPSR 2010;1(1):66-77.
6.
Devprakash, Srinivasan
KK, Subbaraju T, Sachin KS. Antimicrobial Activity of
Alcoholic and Aqueous
Extracts of Tephrosia purpurea. Asian J Biochem Pharma Res2011;2(1): 670-675.
7.
Sandhya S, Venkatramana K, Vinod KR, Chaitanya RK, Chandrasekhar
J at al.,
studied the Membrane
stabilizing potency of
two Tephrosia species.
J Phytol 2010;2(6):42-46.
8.
Lashmi P, Khan AA,
Reddy PN, Lakshminarayana K, Ganapaty S. Genetic relationship Among Tephrosia species
as Revealed by
RAPD Analysis. Asian J
of BiolSci 2008;1(1):1-10.
9.
Dou Shee HH. Tephrosia Persoon. Flora of china 2010;10:190-193.
10.
Shah
R, Rumit
S, Chanda S. Pharmacognostical and Preliminary Phytochemical
Investigation of Tephrosia purpurea
(Linn.) Pers. Root from
Gujarat Region. IJPR 2011;3(2):49-50.
11.
Gandhi H, Balaraman R. Evaluation of
Polyherbal
Formulation ROUTACK in
Rodent Models of
Anaphylaxis. IJPR2011;1(2):87-95.
12.
Arsul VA
, Wagh SR, Mayee RA. Hepatoprotective activity of Livergen, a polyherbal
formulation carbon tetrachloride
induced hepatotoxicity in
rats. Int J Pharm Pharm Sci 2011;3(3):228-231.
13.
Patel
AM, Darade SS,
Jain PG, Kandalkar AM.
Formulation and Evaluation of Proprietary Polyherbal
Formulation for their Hepatoprotective
activity. Int J Pharm Tech Res
2010;2(1):305-309.
14.
Jain A, Lodhi S, Singhai AK.
Simultaneous estimation of quercetin and rutin in Tephrosia purpurea Pers by high
performance thin layer
chromatography. Asian JTrad Med
2009;4(3):104-109.
15.
Valli G, Vasanthi A, Vijayalashmi R, Thanga TA.IJPRD 2011;3(6):211-217.
16.
Siddiqui S, Verma A,
Rather AA, Jabeen F,Meghvansi MK.
Preliminary Phytochemical Analysis
of Some Important
Medicinal and Aromatic
plants. AdvBiol Res
2009;3(5-6):188-195.
17.
Saraf MN, Damre AS, Gokhale AB, Phadke AS, Kulkarni KR. Studiesbon the immunomodulatory activity of flavonoidal
of Tephrosia purpurea. Fitoterapia 2003;74:257-267.
18.
Shah R, Kathad H, Sheth R, Sheth N.In
vitro Antioxidant Activity
of Tephrosia purpurea. Int J Pharmacy
PharmSci
2010;2(3):30-33.
19.
Ahmad VU,
Ali Z, Hussaini SR, Iqbal F, Zahid M at al., studied
the Flavonoids of Tephrosia purpurea. Fitoterapia 1999;70:443-445.
20.
Nirmal SA, Sonawane IL, Dhasade VV,
Rub RA, Mandal SC.Antioxidant effect
of Tephrosia purpurea
roots. IJPSR 2010;1:57-60.
21.
Rao EV, Raju NR.Occurrence
of (-)-isolonchocarpin in
the roots of Tephrosia purpurea. phytochemistry 1979;18:1581-1582.
22.
Rao EV, Raju NR.Two Flavonoids from Tephrosia purpurea, Phytochemistry,
1984, 23(10), 2339-2342.
23.
Ahmad S.
Natural occurrence
of Tephrosia flavones.
Phytochemistry
1986; 25(4):955-958.
24.
Sinha B, Natu AA, Nanavati DD. Prenylated flavonoids from Tephrosia purpurea
seeds.Phytochemistry1982;21(6):1468-1470.
25.
Maurya R, Yadav PP. Furanoflavonoids: an
overview. Nat. Prod.
Rep., 2005;22:400-424.
26.
Yenesew A, Juma WP, Akala HM, Eyase FL, Muiva LM. Terpurinflavone: An antiplasmodial flavones
from the stem
of Tephrosiapurpurea. Phytochemistry letters 2011;4:176-178.
27.
Gupta RK, Krishnamurti M, Parthasarathi
J, Purpurin.
A flavanone from Tephrosia purpurea. Phytochemistry1980;19:
1264.
28.
Parmar VS, Rathore JS, Jain
R, Henderson DA,
Malone JF. Occurrence of
pongamol
as the enol structure
in Tephrosia purpurea. Phytochemistry, 1989;28(2):591-593.
29.
Gupta M, Mazumder UK, Gomathi P, Selvan VT. Antimirobial activity of
methanol extracts of Plumeria
acuminate Ait. leaves and Tephrosia purpurea. Nat Prod
Rep 2008;7(2):102-105.
30.
Abayasekara CL, Rangama BNLD, Panagoda GJ, Senanayake
MRDM, Antimicrobial activity
of Tephrosiapurpurea (Linn.)
Pers. and Mimusopselengi (Linn.) against some
clinical bacterial isolates. J
NatnSci 2009; 37(2):139-145.
31.
Smita S, Shwetha K, Prabhu K, Maradi R, Bairy KL at al.,
studied the Evaluation
of anti-inflammatory activity
of Tephrosia purpurea
in rats.Asian Pac
J Trop Med
2010;3(3):193-195.
32.
Gopalakrishnan S, Vadivel E, Dhanalakshmi K.Anti-inflammatory
and analgesic activities
of Tephrosia purpurea
Linn. aerial and
root extracts. J Phar Res 2010;3(5):1103-1106.
33.
Rama Murthy
MS, Srinivasan M. Hepatoprotective effect
of Tephrosia purpurea
in experimental animals. Indian J
of Pharmacol 1993;25:34-36.
34.
Jain A, Singhai AK, Dixit
VK.A comparative study
of ethanol extract
of leaves of Tephrosiapurpureapers
and the flavonoid isolated
for hepatoprotective activity.
Indian J Phar Sci 2006;68(6):749-743.
35.
Pavana P, Sethupathy S, Manoharan S. Antihyperglymic
and antilipidperoxidative effects
of Tephrosia purpurea seed
extract in Streptozotocin induced
diabetic rats.Indian JClin Biochem 2007;22(1):
77-83.
36.
Asuntha G, Prasannaraju Y, Sujatha D, Prasad
KVSRG.Assessment ofethanolic extract
of Tephrosiapurpurea (L.)
Pers., Fabaceae, activity
on lithium-pilocarpine induced Status epilepticus
and oxidative stress
in Wistar rats. Braz JPharmacog 2009;22:56-61.
37.
Das PK, Chinniah A, Mohapatra S,Goswami S, Mahapatra Aat al.,
studied the potential
of Tephrosia purpurea as
anti-Helicobacter pyroliagent. J Ethanopharmacol 2009;124:642-645.
38.
Akthar R,
Ahmad S, Shaikh T, Mujawar T, Khan M.Antihyperlipidemic
effect of ethanolic
extract of Tephrosia purpurea Linn
in dexamethasone induced
rats. IJRAP 2011;2(1):264-266.
39.
Deshpande SS, Shah GB, Parmar NS. Antiulcer activity of Tephrosia purpurea in rats. Indian J Pharmacol 2003;35:168-172.
40.
Soni K,
Kumar PS, Saraf MN. Antioxidant activity of
fraction of Tephrosia purpurea Linn. Indian J
PharmSci
2006; 68(4):234-238.
41.
Singhai AK, Santram L, Pawar RS,
Jain AP.Wound healing
potential of Tephrosia purpurea, (Linn.) Pers. in rats. J Ethnopharmol 2006;108:204-210.
42.
Gokhale A, Saraf MN. Influence of Ethanolic Extract
of Tephrosia purpurea Linn. on the
Late-phase of Allergic
Reaction. Indian J
Pharm Sci
2000;62(5):356-359.
43.
Kavitha K,
Manoharan S. Anticarcinogenic
and antilipidperoxidative effects of Tephrosia purpurea (Linn.) Pers.
in7,12-dimethylbenz(a)anthracene
(DMBA) induced hamster
buccal
pouch carcinoma. Indian J. Pharmacol
2006;38(3):185-89.
44. Suvidha SS, AnujaP. Evaluation of
pharmacognostical, phytochemical
and pharmacological activity
of Tephrosia purpurea (Linn.). IJPRD 2009; 1(5):1-4.
45. Kumar AS, Amudha P, Kannan CS.
Evaluation of anxiolytic activity
of hydroalcoholic activity
of Tephrosia purpurea (L) Pers on Swiss albino
mice. IJPSR 2011;2(5):1262-1269.
Received on 23.01.2012
Modified on 07.02.2012
Accepted on 12.02.2012
© A&V Publication all right reserved
Research Journal of Pharmacognosy and Phytochemistry.
4(2): March-April 2012,
134-143